NCT05165056View on ClinicalTrials.gov

Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity

NARecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Radiotherapy Side EffectVaginal Abnormality
Interventions
DEVICE

Intimleds

INTIMILEDS® is a photobiomodulation device designed for intravaginal use. It's design permits an irradiation of the whole vaginal wall, the vulva, and the cervix, with a constant intensity.

Trial Locations (2)

3500

RECRUITING

Jessa Hospital, Hasselt

3600

RECRUITING

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
collaborator

Ziekenhuis Oost-Limburg

OTHER

collaborator

Hasselt University

OTHER

lead

Jessa Hospital

OTHER